Synergism of Cisplatin-oleanolic Acid Co-loaded Hybrid Nanoparticles on Gastric Carcinoma Cells for Enhanced Apoptosis and Reversed Multidrug Resistance

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2020 Jan 12

PMID 31924110

Citations 13

Authors

Danyang Li

Ruixue Cui

Shuning Xu

Ying Liu

Affiliations

Soon will be listed here.

Abstract

Combined administration of different drugs is a widely acknowledged approach for effective cancer therapy. However, the limited targeting, as well as inferior drug loading capacities of current drug delivery systems (DDS), are still the bottleneck for better performance in cancer treatment. Herein, we successfully developed a cancer cell membrane (CM) decorated calcium carbonate (CC) hybrid nanoparticles (HN) for the co-delivery of cisplatin (CDDP) and oleanolic acid (OA). The physicochemical property of HN/CDDP/OA was evaluated, which revealed that the as-prepared DDS was core-shell structured and well-dispersed nanoparticles with size around 100 nm. The HN/CDDP/OA showed high stability and biocompatibility with pH-responsive drug release. Moreover, the CM modification in HN also demonstrated highly elevated tumor-homing nature than bare CC. Finally, the feasibility of HN/CDDP/OA in the treatment of gastric cancer (MGC-803 cell line) was assessed. HN/CDDP/OA showed better performance than mono systems with enhanced apoptosis and capable of reversing multidrug resistance (MDR) of cancer cells.

Citing Articles

Modified decoction alleviates 5-fluorouracil-induced intestinal mucositis by modulating the TLR4/MyD88/NF-κB pathway and gut microbiota.

Qiu Y, Luo X, Deng Y, Zheng X, Qiu J, Zhang L World J Gastroenterol. 2025; 31(7):98806.

PMID: 39991674 PMC: 11755253. DOI: 10.3748/wjg.v31.i7.98806.

Plant In Vitro Culture Factories for Pentacyclic Triterpenoid Production.

Badjakov I, Dincheva I, Vrancheva R, Georgiev V, Pavlov A Adv Biochem Eng Biotechnol. 2024; 188:17-49.

PMID: 38319391 DOI: 10.1007/10_2023_245.

Preparation, Characterization, and Evaluation of the Anticancer Effect of Mesoporous Silica Nanoparticles Containing Rutin and Curcumin.

Dizaj S, Kouhsoltani M, Pourreza K, Sharifi S, Abdolahinia E Pharm Nanotechnol. 2023; 12(3):269-275.

PMID: 37594097 DOI: 10.2174/2211738511666230818092706.

Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers.

Kumar G, Virmani T, Sharma A, Pathak K Pharmaceutics. 2023; 15(3).

PMID: 36986748 PMC: 10055866. DOI: 10.3390/pharmaceutics15030889.

Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti....

Yan J, Guo J, Wang Y, Xing X, Zhang X, Zhang G Drug Deliv. 2022; 29(1):2815-2823.

PMID: 36047255 PMC: 9487946. DOI: 10.1080/10717544.2022.2118401.

References

Man D, Casettari L, Cespi M, Bonacucina G, Palmieri G, Sze S . Oleanolic Acid Loaded PEGylated PLA and PLGA Nanoparticles with Enhanced Cytotoxic Activity against Cancer Cells. Mol Pharm. 2015; 12(6):2112-25. DOI: 10.1021/acs.molpharmaceut.5b00085. View

Wang C, Wang Z, Zhao X, Yu F, Quan Y, Cheng Y . DOX Loaded Aggregation-induced Emission Active Polymeric Nanoparticles as a Fluorescence Resonance Energy Transfer Traceable Drug Delivery System for Self-indicating Cancer Therapy. Acta Biomater. 2018; 85:218-228. DOI: 10.1016/j.actbio.2018.12.020. View

Wang C, Liu X, Chen S, Hu F, Sun J, Yuan H . Facile preparation of phospholipid-amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration. Chem Commun (Camb). 2018; 54(93):13080-13083. DOI: 10.1039/c8cc07694d. View

Tan L, Ma B, Zhao Q, Zhang L, Chen L, Peng J . Toxicity Evaluation and Anti-Tumor Study of Docetaxel Loaded mPEG-Polyester Micelles for Breast Cancer Therapy. J Biomed Nanotechnol. 2018; 13(4):393-408. View

Wang C, Yu F, Liu X, Chen S, Wu R, Zhao R . Cancer-Specific Therapy by Artificial Modulation of Intracellular Calcium Concentration. Adv Healthc Mater. 2019; 8(18):e1900501. DOI: 10.1002/adhm.201900501. View

Xue J, Zhao Z, Zhang L, Xue L, Shen S, Wen Y . Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol. 2017; 12(7):692-700. DOI: 10.1038/nnano.2017.54. View

Meng Z, Zhou X, Xu J, Han X, Dong Z, Wang H . Light-Triggered In Situ Gelation to Enable Robust Photodynamic-Immunotherapy by Repeated Stimulations. Adv Mater. 2019; 31(24):e1900927. DOI: 10.1002/adma.201900927. View

Wang C, Chen S, Yu Q, Hu F, Yuan H . Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells. J Mater Chem B. 2020; 5(11):2068-2073. DOI: 10.1039/c6tb02826h. View

Natarajan A, Gruettner C, Ivkov R, Denardo G, Mirick G, Yuan A . NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. Bioconjug Chem. 2008; 19(6):1211-8. PMC: 3573696. DOI: 10.1021/bc800015n. View

10.

Sun S, Gebauer D, Colfen H . A solvothermal method for synthesizing monolayer protected amorphous calcium carbonate clusters. Chem Commun (Camb). 2016; 52(43):7036-8. DOI: 10.1039/c6cc03010f. View

11.

Rao L, Bu L, Cai B, Xu J, Li A, Zhang W . Cancer Cell Membrane-Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging. Adv Mater. 2016; 28(18):3460-6. DOI: 10.1002/adma.201506086. View

12.

Negi L, Talegaonkar S, Jaggi M, Verma A . Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an , and mechanistic investigation. J Drug Target. 2018; 27(2):183-192. DOI: 10.1080/1061186X.2018.1497039. View

13.

Tang Q, Chen D, Xue W, Xiang J, Gong Y, Zhang L . Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo. Int J Nanomedicine. 2011; 6:3077-85. PMC: 3235028. DOI: 10.2147/IJN.S24322. View

14.

Yalcin S, Ozluer O, Gunduz U . Nanoparticle-based drug delivery in cancer: the role of cell membrane structures. Ther Deliv. 2016; 7(11):773-781. DOI: 10.4155/tde-2016-0056. View

15.

Xiong H, Wu Y, Jiang Z, Zhou J, Yang M, Yao J . pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release. J Colloid Interface Sci. 2018; 536:135-148. DOI: 10.1016/j.jcis.2018.10.039. View

16.

Zou Z, Zou R, Zong D, Shi Y, Chen J, Huang J . miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression. J Cell Mol Med. 2017; 21(9):1929-1943. PMC: 5571520. DOI: 10.1111/jcmm.13114. View

17.

Li S, Zhao Q, Wang B, Yuan S, Wang X, Li K . Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Phytother Res. 2018; 32(8):1530-1536. DOI: 10.1002/ptr.6081. View

18.

Wen L, Liang C, Chen E, Chen W, Liang F, Zhi X . Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent. Sci Rep. 2016; 6:23269. PMC: 4806320. DOI: 10.1038/srep23269. View

19.

Tang D, Zhao X, Yang T, Wang C . Correction: Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy. RSC Adv. 2022; 10(23):13552. PMC: 9128721. DOI: 10.1039/d0ra90029j. View

20.

Semalty A, Semalty M, Rawat B, Singh D, Rawat M . Pharmacosomes: the lipid-based new drug delivery system. Expert Opin Drug Deliv. 2009; 6(6):599-612. DOI: 10.1517/17425240902967607. View